Clinical data from the RESET-Myositis™ and RESET-SLE™ trials ... containing a fully human CD19 binder and a 4-1BB co-stimulatory domain as a potential treatment for a broad range of autoimmune ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback